Aerovate Therapeutics Emerges From RA Capital Incubator With $72.6 Million Funding for Potential Disease-Modifying Pulmonary Arterial Hypertension Therapy

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3klbVXC
via IFTTT